Sort
46,585 grants matching “heart failure”
Pharmacologic Treatment of Mitochondrial Complex I Dysfunction in C. Elegans
$537,180Marni J Falk · Children'S Hosp Of Philadelphia · R01 · FY2016 · GM
Hypothalamic neuron activation to blunt myocardial remodeling during chronic sleep apnea
$537,150Matthew W. Kay · George Washington University · R01 · FY2021 · HL
Characteristics and impact of chronic pain and pain management in older adults
$537,136Christine S Ritchie · Massachusetts General Hospital · R01 · FY2024 · AG
Implementation of Computerized Clinical Support for Mechanical Ventilation of Patients with Acute Respiratory Distress Syndrome
$537,052Colin Kerst Grissom · Ihc Health Services, Inc. · U01 · FY2019 · HL
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activation
$536,932Brian C Jensen · Univ Of North Carolina Chapel Hill · R01 · FY2024 · HL
Somatic TET2 mutations in cardiac remodeling
$536,880Kenneth Walsh · Boston University Medical Campus · R01 · FY2017 · HL
Molecular insights into the effects of SARS-Cov2 infection on the blood system
$536,871Naoko Mizuno · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Genetic Metabolic Myopathies--phosphofructokinase/acid Maltase Deficiency
$536,858Vittorio Sartorelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2011 · AR
Longitudinal Cardiotoxicity in Adult Survivors Childhood Cancer
$536,801Gregory Armstrong · St. Jude Children'S Research Hospital · R01 · FY2016 · CA
Engineering Human Heart Tissues with Polyploid Cardiomyocytes
$536,797Nenad Bursac · Duke University · R01 · FY2024 · HL
Racial and Ethnic Health Disparities Due to Ambulance Diversion
$536,774Amresh D Hanchate · Boston Medical Center · R01 · FY2016 · HL
Targeting Metabo-Redox Network Vulnerability in Heart Failure and Sudden Death
$536,757Brian O'Rourke · Johns Hopkins University · R01 · FY2021 · HL
Optimized Stents for the Femoropopliteal Artery
$536,734Alexey Kamenskiy · University Of Nebraska Omaha · R01 · FY2023 · HL
Optimized Stents for the Femoropopliteal Artery
$536,734Alexey Kamenskiy · University Of Nebraska Omaha · R01 · FY2021 · HL
Optimized Stents for the Femoropopliteal Artery
$536,734Alexey Kamenskiy · University Of Nebraska Omaha · R01 · FY2022 · HL
Scalable Units for Building Vascularized Cardiac Graft
$536,696Lisa E Freed · Massachusetts Institute Of Technology · R01 · FY2014 · HL
Novel signaling pathways underlying skeletal muscle atrophy
$536,608Christopher M Adams · University Of Iowa · R01 · FY2018 · AG
Adipose Derived Cell Therapy for Myocardial Infarction
$536,575Cytori Therapeutics, Inc. · R44 · FY2005 · HL
HALF-PINT: Heart And Lung Failure - Pediatric INsulin Titration trial - DCC
$536,564David Wypij · Boston Children'S Hospital · U01 · FY2013 · HL
Determining the Role of the Potassium Channel, KCNN3, in Atrial Fibrillation
$536,539Patrick Thomas Ellinor · Massachusetts General Hospital · R01 · FY2011 · HL
Decision Making at the End of Life: A Mixed Methods Study
$536,534Joseph John Gallo · Johns Hopkins University · R01 · FY2016 · NR
Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ Dynamics
$536,516Gyorgy Csordas · Thomas Jefferson University · R01 · FY2024 · HL
Early Identification of Childhood Cancer Survivors at High Risk for Late Onset Cardiomyopathy: An Artificial Intelligence Approach utilizing Electrocardiography
$536,471Oguz Akbilgic · Wake Forest University Health Sciences · R01 · FY2024 · CA
Understanding and Manipulating G Protein α Subunit and Phospholipase C Signaling Networks
$536,377Alan V. Smrcka · University Of Michigan At Ann Arbor · R35 · FY2025 · GM
Understanding and Manipulating G Protein α Subunit and Phospholipase C Signaling Networks
$536,377Alan V. Smrcka · University Of Michigan At Ann Arbor · R35 · FY2024 · GM